Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential Of Fosgonimeton For Alzheimer’s And Parkinson’s Diseases At AD/PD 2023 International Conference
Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today presented preclinical data